Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection

被引：218

作者：

Okano, M

Kawa, K

Kimura, H

Yachie, A

Wakiguchi, H

Maeda, A

Imai, S

Ohga, S

Kanegane, H

Tsuchiya, S

Morio, T

Mori, M

Yokota, S

Imashuku, S

机构：

[1] Hokkaido Univ, Grad Sch Med, Hokkaido Univ Hosp, Dept Pediat, Sapporo, Hokkaido, Japan

[2] Osaka Med Ctr, Dept Pediat, Izumi, Japan

[3] Res Inst Maternal & Child Hlth, Izumi, Japan

[4] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan

[5] Kanazawa Univ, Sch Med, Fac Med, Sch Hlth Sci, Kanazawa, Ishikawa, Japan

[6] Kochi Med Sch, Dept Pediat, Nankoku, Kochi, Japan

[7] Kochi Med Sch, Dept Mol Microbiol & Infect, Nankoku, Kochi, Japan

[8] Kyushu Univ, Sch Med, Grad Sch Med Sci, Dept Pediat, Fukuoka, Japan

[9] Toyama Med & Pharmaceut Univ, Dept Pediat, Toyama, Japan

[10] Tohoku Univ, Inst Dev Aging & Canc, Dept Pediat, Sendai, Miyagi, Japan

[11] Tokyo Med & Dent Univ, Grad Sch, Dept Pediat & Dev Biol, Tokyo, Japan

[12] Yokohama City Univ, Sch Med, Dept Pediat, Yokohama, Kanagawa, Japan

[13] Takasago Seibu Hosp, Dept Pediat, Takasago, Hyogo, Japan

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2005年 / 80卷 / 01期

关键词：

guidelines; diagnosis; chronic active Epstein-Barr virus infection;

D O I：

10.1002/ajh.20398

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Since the initial report of unusual manifestations possibly associated with chronic active Epstein-Barr virus (EBV) infection (CAEBV), nearly three decades have passed. During this period, reported cases with this entity have dramatically increased in the world. Additionally, recent development of diagnostic procedures, including molecular biological and immunological techniques, have provided us with the ability to define certain diseases, especially malignant disorders. Guidelines, derived mainly from the current literature and recent experiences with CAEBV in Japan, for diagnosing CAEBV are proposed to clarify this enigmatic disease.

引用

页码：64 / 69

页数：6

共 52 条

[31]

2-Y

[32] Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome [J].